Team

Teambild
AG Klinische Psychologie

Univ.-Prof. Dr. Yvonne Nestoriuc, Dipl.-Psych.

 
Bild Nestoiuc
Raum:
228
Telefon:
(040) 6541-2911
Fax:
(040) 6541-2040
Besucheranschrift
Helmut-Schmidt-Universität
Gebäude H4
Holstenhofweg 85
22043 Hamburg
Postanschrift
Helmut-Schmidt-Universität
Professur für Klinische Psychologie
Postfach 70 08 22
22008 Hamburg
 

Sprechzeiten Mo., 11:30-12:30 Uhr, nach vorheriger Anmeldung. Um einen persönlichen Termin mit mir zu vereinbaren, wenden Sie sich bitte via E-Mail an Frau Michèle Pester.

Lebenslauf Frau Prof. Dr. Y. Nestoriuc, Dipl.-Psych.

Research Gate

2022

  • Gerke, L., Meyrose, A. K., & Nestoriuc, Y. (2022). Informed consent for psychotherapy: Ethical illusion or clinical reality? A survey about psychotherapists‘ attitudes and practices in Germany. Clinical Psychology & Psychotherapy.
  • Pan, Y., Frank, M. L., Kaptchuk, T. J., & Nestoriuc, Y. (2022). “Let’s see what happens:”—Women’s experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial. Plos one, 17(11), e0276499.
  • Meijers, M. C., Stouthard, J., Evers, A. W. M., Das, E., Drooger, H. J., Jansen, S. J. A. J., … , Nestoriuc, Y., … & van Vliet, L. M. (2022). Possible alleviation of symptoms and side effects through clinicians’ nocebo information and empathy in an experimental video vignette study. Scientific reports, 12(1), 1-12.
  • Uhlenbusch, N., Manthey, C., Nestoriuc, Y., Andresen, V., Lohse, A. W., & Löwe, B. (2022). Psychosocial Support for People with Ulcerative Colitis and Irritable Bowel Syndrome: A Feasibility Study on Need, Focus and Viability. Psychotherapie, Psychosomatik, Medizinische Psychologie.
  • von Blanckenburg, P., Knorrenschild, J. R., Hofmann, M., Fries, H., Nestoriuc, Y., Seifart, U., … & Seifart, C. (2022). Expectations, end-of-life fears and end-of-life communication among palliative patients with cancer and caregivers: a cross-sectional study. BMJ open, 12(5), e058531.
  • Nestoriuc, Y. (2022). Expectation effects in antidepressant discontinuation. PSYCHOTHERAPEUT, 67(3), 213-219.
  • Löwe B, Nestoriuc Y, Andresen V, Vettorazzi E, Zapf A, Hübener S, Maehder K, Peters L, Lohse AW. Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT). BMJ Open. 2022 Jun 14;12(6):e059529. doi: 10.1136/bmjopen-2021-059529 . PMID: 35701050 ; PMCID: PMC9198710.
  • Nestoriuc, Y., Pauls, F., Kirchhof, S., Loewe, B., & Toussaint, A. (2022, January). Modifiable factors influencing persistent body complaints in somatic stress disorder. In ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE (Vol. 68, No. 2, pp. 191-191). VIENNA UNIV PRESS, ROBERT BOSCH BREITE 6, D-37079 GOTTINGEN, GERMANY: VANDENHOECK & RUPRECHT GMBH & CO KG
  • Löwe, B., Andresen, V., Van den Bergh, O., Huber, T. B., von dem Knesebeck, O., Lohse, A. W., Nestoriuc, Y., … & Toussaint, A. (2022). Persistent SOMAtic symptoms ACROSS diseases—from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211). BMJ open, 12(1), e057596.

2021

  • Eberle, K., Inderbinen, M., Gaab, J., Nestoriuc, Y., & Trachsel, M. (2021). Informed consent in psychotherapy: a survey on attitudes among psychotherapists in Switzerland. BMC medical ethics, 22(1), 1-10.
  • Michnevich, T. L., Pan, Y., Hendi, A., Oechsle, K., Stein, A., & Nestoriuc, Y. (2021). Preventing Adverse Events of Chemotherapy for Gastrointestinal Cancer by Educating Patients about the Nocebo Effect: A Randomized-controlled Trial.
  • Nestoriuc, Y., & Gerke, L. (2021, October). Kommunikative Herausforderungen im klinischen Alltag. In Forum (Vol. 36, No. 5, pp. 369-374). Springer Medizin.
  • Gerke, L., Ladwig, S., Pauls, F., Härter, M., & Nestoriuc, Y. (2021). Informed Consent for Psychotherapy: A Randomized Controlled Trial evaluating the Efficacy of an Optimized Informed Consent on Treatment Expectations and Capacity to Consent.
  • Nestoriuc, Y., Pan, Y., Kinitz, T., Weik, E., & Shedden-Mora, M. C. (2021). Informing about the nocebo effect affects patients’ need for information about antidepressants—an experimental online study. Frontiers in Psychiatry, 12, 587122.
  • Dietrichkeit, M., Hagemann-Goebel, M., Nestoriuc, Y., Moritz, S., & Jelinek, L. (2021). Side effects of the metacognitive training for depression compared to a cognitive remediation training in patients with depression. Scientific Reports, 11(1), 1-10.
  • Rief, W., Nestoriuc, Y., Mueller, E. M., Hermann, C., Schmidt, K., & Bingel, U. (2021). Generic rating scale for previous treatment experiences, treatment expectations, and treatment effects (GEEE).

2020

  • Pan, Y., Meister, R., Löwe, B., Kaptchuk, T. J., Buhling, K. J., & Nestoriuc, Y. (2020). Open-label placebos for menopausal hot flushes: a randomized controlled trial. Scientific reports, 10(1), 1-15. https://doi.org/10.1038/s41598-020-77255-z
  • Alberts, J., Löwe, B., Glahn, M. A., Petrie, K., Laferton, J., Nestoriuc, Y., & Shedden-Mora, M. (2020). Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews. BMJ Open, 10(8), e036169. https://doi.org/10.1136/bmjopen-2019-036169
  • Gerke, L., Meyrose, A.-K., Ladwig, I., Rief, W., & Nestoriuc, Y. (2020). Frequencies and Predictors of Negative Effects in Routine Inpatient and Outpatient Psychotherapy: Two Observational Studies. Frontiers in Psychology, 11, 2144. https://doi.org/10.3389/fpsyg.2020.02144
  • Nestoriuc, Y., & Kleine-Borgmann, J. (2020). Der Schein trügt nicht – klinische Evidenz und neue Forschungsansätze zum Open-label-Placebo. Der Nervenarzt, 1-6. https://doi.org/10.1007/s00115-020-00953-6
  • Shedden-Mora, M. C., Pan, Y., Heisig, S. R., von Blanckenburg, P., Rief, W., Witzel, I., Albert, U.-S., & Nestoriuc, Y. (2020). Optimizing expectations about endocrine treatment for breast cancer: Results of the randomized controlled psy-breast trial. Clinical Psychology in Europe, 2(1), e2695. https://doi.org/10.32872/cpe.v2i1.2695
  • Bowers, H. M., Kendrick, T., Glowacka, M., Williams, S., Leydon, G., May, C., Dowrick, C., Moncrieff, J., Laine, R., Nestoriuc, Y., Andersson, G., & Geraghty, A. W. A. (2020). Supporting antidepressant discontinuation: The development and optimisation of a digital intervention for patients in UK primary care using a theory, evidence and person-based approach. BMJ Open, 10(3), e032312. https://doi.org/10.1136/bmjopen-2019-032312
  • Meister, R., Abbas, M., Antel, J., Peters, T., Pan, Y., Bingel, U., Nestoriuc, Y., & Hebebrand, J. (2020). Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: A systematic review and meta-regression analysis. European Child & Adolescent Psychiatry, 29(3), 253–273. https://doi.org/10.1007/s00787-018-1244-7
  • Seifart, C., Riera Knorrenschild, J., Hofmann, M., Nestoriuc, Y., Rief, W., & von Blanckenburg, P. (2020). Let us talk about death: Gender effects in cancer patients’ preferences for end-of-life discussions. Supportive Care in Cancer, 1-9. https://doi.org/10.1007/s00520-019-05275-1
  • Meister, R., Lanio, J., Fangmeier, T., Härter, M., Schramm, E., Zobel, I., Hautzinger, M., Nestoriuc, Y., & Kriston, L. (2020). Adverse events during a disorder‐specific psychotherapy compared to a nonspecific psychotherapy in patients with chronic depression. Journal of Clinical Psychology, 76(1), 7–19. https://doi.org/10.1002/jclp.22869

2019

  • Koch, J., Riera-Knorrenschild, J., Von Blanckenburg, P., Nestoriuc, Y., Rief, W., & Hoffmann, M. (2019). OP16 Let’s talk about death: Gender effects in cancer patient’s preferences for end-of-life. Oral Presentations, A6.1-A6. https://doi.org/10.1136/spcare-2019-ACPICONGRESSABS.16
  • Pan, Y., Meister, R., Löwe, B., Winkelmann, A., Kaptchuk, T. J., Buhling, K. J., & Nestoriuc, Y. (2019). Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial. Trials, 20(1), 508. https://doi.org/10.1186/s13063-019-3575-1
  • Moritz, S., Nestoriuc, Y., Rief, W., Klein, J. P., Jelinek, L., & Peth, J. (2019). It can’t hurt, right? Adverse effects of psychotherapy in patients with depression. European Archives of Psychiatry and Clinical Neuroscience, 269(5), 577–586. https://doi.org/10.1007/s00406-018-0931-1
  • Shedden-Mora, M., Alberts, J., Petrie, K., Laferton, J., Nestoriuc, Y., & Löwe, B. (2019). The treatment expectation questionnaire (TEX-Q)–A generic multidimensional scale measuring patients‘ treatment expectations. Journal of Psychosomatic Research, 121, 129-130.
  • Meyer, B., Weiss, M., Holtkamp, M., Arnold, S., Brückner, K., Schröder, J., Scheibe, F., & Nestoriuc, Y. (2019). Effects of an epilepsy‐specific Internet intervention (Emyna) on depression: Results of the ENCODE randomized controlled trial. Epilepsia, 60(4), 656–668. https://doi.org/10.1111/epi.14673
  • Helle, N., Barkmann, C., Ehrhardt, S., von der Wense, A., Nestoriuc, Y., & Bindt, C. (2019). Internalizing symptoms in very low birth weight preschoolers: Symptom level and risk factors from four rating perspectives in a controlled multicenter study. Journal of Affective Disorders, 246, 74–81. https://doi.org/10.1016/j.jad.2018.12.025
  • Nestoriuc, Y., & Gerke, L. (2019). Was sind Risiken und Nebenwirkungen von Psychotherapie? Verband psychologischer Psychotherapeutinnen und Psychotherapeuten im BDP e.V., 47, 4-6.
  • Christalle, E., Zill, J. M., Frerichs, W., Härter, M., Nestoriuc, Y., Dirmaier, J., & Scholl, I. (2019). Assessment of patient information needs: A systematic review of measures. PLOS ONE, 14(1), e0209165. https://doi.org/10.1371/journal.pone.0209165
  • Michnevich, T., Pan, Y., Mann, J., Salm, M., Hendi, A., Nilsson, S., … & Nestoriuc, Y. (2019, January). Preventing adverse effects of chemotherapy by educating patients about the nocebo effect. In Zeitschrift für psychosomatische Medizin und Psychotherapie (Vol. 66, No. 1, pp. 92-93). Vienna Univ Press, Robert Bosch Breite 6, D-37079 Göttingen, Germany: Vandenhoeck & Ruprecht GmbH & Co KG.
  • Pan, Y., Kinitz, T., Stapic, M., & Nestoriuc, Y. (2019). Minimizing Drug Adverse Events by Informing About the Nocebo Effect—An Experimental Study. Frontiers in Psychiatry, 10, 504. https://doi.org/10.3389/fpsyt.2019.00504

2018

  • Quidde, J., Pan, Y., Salm, M., Hendi, A., Nilsson, S., Oechsle, K., Stein, A., & Nestoriuc, Y. (2018). Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) – study protocol of a randomized controlled trial with gastrointestinal cancer patients. BMC Cancer, 18(1), 916. https://doi.org/10.1186/s12885-018-4814-7
  • Shedden-Mora, M., Pan, Y., Heisig, S., von Blanckenburg, P., Rief, W., Witzel, I., … & Nestoriuc, Y. (2018). Optimizing Expectations About Endocrine Treatment for Breast Cancer: Results of the Randomized Controlled PSY-BREAST Trial. In International Journal of Behavioral Medicine  (Vol. 25, pp. S182-S182). 233 Spring St, New York, NY 10013 USA: Springer.
  • Shedden-Mora, M., Alberts, J., Petrie, K., Laferton, J., Nestoriuc, Y., & Loewe, B. (2018, October). The Treatment Expectation Questionnaire (TEX-Q) Development of a generic multidimensional measure assessing patient expectations of medical and psychological treatments. In International Journal of Behavioral Medicine (Vol. 25, pp. S218-S218). 233 Spring St, New York, NY 10013 USA: Springer.
  • Linden, M., Strauß, B., Scholten, S., Nestoriuc, Y., Brakemeier, E. L., & Wasilewski, J. (2018). Definition and decision-making in the determination and detection of side effects of psychotherapy. PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 68(9-10), 377-382. https://doi.org/10.1055/a-0619-5949
  • Linden, M., Strauß, B., Scholten, S., Nestoriuc, Y., Brakemeier, E.-L., & Wasilewski, J. (2018). Definition und Entscheidungsschritte in der Bestimmung und Erfassung von Nebenwirkungen von Psychotherapie. PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 68(09/10), 377–382. https://doi.org/10.1055/a-0619-5949
  • Bieda, A., Pflug, V., Scholten, S., Lippert, M., Ladwig, I., Nestoriuc, Y., & Schneider, S. (2018). Unerwünschte Nebenwirkungen in der Kinder- und Jugendlichenpsychotherapie – Eine Einführung und Empfehlungen. PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 68(09/10), 383–390. https://doi.org/10.1055/s-0044-102291
  • Bieda, A., Pflug, V., Scholten, S., Lippert, M. W., Ladwig, I., Nestoriuc, Y., & Schneider, S. (2018). Unwanted Side Effects in Children and Youth Psychotherapy-Introduction and Recommendations. PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 68(09/10), 383–390. https://doi.org/10.1055/s-0044-102291
  • Peth, J., Jelinek, L., Nestoriuc, Y., & Moritz, S. (2018). Unerwünschte Effekte von Psychotherapie bei depressiven Patienten – Erste Anwendung der Positive and Negative Effects of Psychotherapy Scale (PANEPS). PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 68(09/10), 391–398. https://doi.org/10.1055/s-0044-101952
  • Peth, J., Jelinek, L., Nestoriuc, Y., & Moritz, S. (2018). Adverse Effects of Psychotherapy in Depressed Patients-First Application of the Positive and Negative Effects of Psychotherapy Scale (PANEPS). PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 68(09/10), 391–398. https://doi.org/10.1055/s-0044-101952
  • Aust, H., Eberhart, L., Sturm, T., Schuster, M., Nestoriuc, Y., Brehm, F., & Rüsch, D. (2018). A cross-sectional study on preoperative anxiety in adults. Journal of Psychosomatic Research, 111, 133–139. https://doi.org/10.1016/j.jpsychores.2018.05.012
  • Pan, Y., Heisig, S. R., von Blanckenburg, P., Albert, U.-S., Hadji, P., Rief, W., & Nestoriuc, Y. (2018). Facilitating adherence to endocrine therapy in breast cancer: Stability and predictive power of treatment expectations in a 2-year prospective study. Breast Cancer Research and Treatment, 168(3), 667–677. https://doi.org/10.1007/s10549-017-4637-2

2017

  • Hahlweg, P., Didi, S., Kriston, L., Härter, M., Nestoriuc, Y., & Scholl, I. (2017). Process quality of decision-making in multidisciplinary cancer team meetings: A structured observational study. BMC Cancer, 17(1), 772. https://doi.org/10.1186/s12885-017-3768-5
  • Graef, J. E., Rief, W., Nestoriuc, Y., & Weise, C. (2017). The More Vivid the Imagination the Better: The Role of the Vividness of Imagination in Vasoconstriction Training and Vasodilatation Training. Applied Psychophysiology and Biofeedback, 42(4), 283–298. https://doi.org/10.1007/s10484-017-9373-1
  • Meyer, B., Weiss, M., Holtkamp, M., Arnold, S., Brückner, K., Schröder, J., Scheibe, F., & Nestoriuc, Y. (2017). Protocol for the ENCODE trial: Evaluating a novel online depression intervention for persons with epilepsy. BMC Psychiatry, 17(1), 55. https://doi.org/10.1186/s12888-017-1229-y
  • Hahlweg, P., Härter, M., Nestoriuc, Y., & Scholl, I. (2017). How are decisions made in cancer care? A qualitative study using participant observation of current practice. BMJ Open, 7(9), e016360. https://doi.org/10.1136/bmjopen-2017-016360
  • Gierk, B., Kohlmann, S., Hagemann-Goebel, M., Löwe, B., & Nestoriuc, Y. (2017). Monitoring somatic symptoms in patients with mental disorders: Sensitivity to change and minimal clinically important difference of the Somatic Symptom Scale – 8 (SSS-8). General Hospital Psychiatry, 48, 51–55. https://doi.org/10.1016/j.genhosppsych.2017.07.002
  • Arlt, A. D., Nestoriuc, Y., & Rief, W. (2017). Why current drug adherence programs fail: Addressing psychological risk factors of nonadherence. Current Opinion in Psychiatry, 30(5), 326–333. https://doi.org/10.1097/YCO.0000000000000345
  • Shedden-Mora, M., Heisig, S., Von Blanckenburg, P., Witzel, I., Rief, W., Albert, U. S., & Nestoriuc, Y. (2017). Optimizing expectations to prevent side effects of adjuvant endocrinetreatment in breast cancer: A randomized controlled trial. Journal of Psychosomatic Research, 97, 167-168.
  • Meister, R., Jansen, A., Härter, M., Nestoriuc, Y., & Kriston, L. (2017). Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis. Journal of Affective Disorders, 215, 288–298. https://doi.org/10.1016/j.jad.2017.03.024
  • Kampermann, L., Nestoriuc, Y., & Shedden-Mora, M. C. (2017). Physicians’ beliefs about placebo and nocebo effects in antidepressants – an online survey among German practitioners. PLOS ONE, 12(5), e0178719. https://doi.org/10.1371/journal.pone.0178719
  • Braunegger, D., & Nestoriuc, Y. (2017). Kann eine optimierte Medikamentenaufklarung Nebenwirkungen minimieren und die Behandlungswirkung maximieren? Eine Online-Studie zur Erwartungsmodulation. Zeitschrift für Psychosomatische Medizin und Psychotherapie, 63(1), 43-45.
  • Rief, W., Seifart, C., & Nestoriuc, Y. (2017). New Developments in Psycho-oncology. In Cancer Genetics and Psychotherapy (pp. 31-43). Springer, Cham.
  • Braunegger, D., & Nestoriuc, Y. (2017). Can an optimized Drug Discovery minimize Side Effects and maximize the Treatment Efficacy? An Online Study on Expectancy Modulation. Zeitschrift für Psychosomatische Medizin und Psychotherapie, 63(1), 43-45. Göttingen, Germany: Vandenhoeck & Ruprecht.
  • Graef, J., Rief, W., Korn, H.-J., Timmer, B., Martin, A., & Nestoriuc, Y. (2017). Pilotstudie zur Durchführbarkeit einer Biofeedbackkompaktbehandlung bei chronifizierten Kopfschmerzen in der ambulanten Versorgung. PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 67(01), 26–37. https://doi.org/10.1055/s-0042-112462

2016

  • Aust, H., Rüsch, D., Schuster, M., Sturm, T., Brehm, F., & Nestoriuc, Y. (2016). Coping strategies in anxious surgical patients. BMC Health Services Research, 16(1), 250. https://doi.org/10.1186/s12913-016-1492-5
  • Heisig, S. R., Shedden-Mora, M. C., von Blanckenburg, P., Rief, W., Witzel, I., Albert, U.-S., & Nestoriuc, Y. (2016). What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy: Treatment expectations. Psycho-Oncology, 25(12), 1485–1492. https://doi.org/10.1002/pon.4089
  • Nestoriuc, Y., von Blanckenburg, P., Schuricht, F., Barsky, A. J., Hadji, P., Albert, U.-S., & Rief, W. (2016). Is it best to expect the worst? Influence of patients’ side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Annals of Oncology, 27(10), 1909–1915. https://doi.org/10.1093/annonc/mdw266
  • Graef, J., Rief, W., Korn, H.-J., Timmer, B., Martin, A., & Nestoriuc, Y. (2016). Pilotstudie zur Durchführbarkeit einer Biofeedbackkompaktbehandlung bei chronifizierten Kopfschmerzen in der ambulanten Versorgung. PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 67(01), 26–37. https://doi.org/10.1055/s-0042-112462
  • Graef, J. E., Rief, W., Korn, H. J., Timmer, B., Martin, A., & Nestoriuc, Y. (2016). Pilot Study of the Feasibility of a Short Biofeedback Treatment of Chronic Headache in the Outpatient Care System. PPmP – Psychotherapie · Psychosomatik · Medizinische Psychologie, 67(1), 26-37. https://doi.org/10.1055/s-0042-112462
  • Meister, R., von Wolff, A., Mohr, H., Härter, M., Nestoriuc, Y., Hölzel, L., & Kriston, L. (2016). Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis. PLOS ONE, 11(5), e0153380. https://doi.org/10.1371/journal.pone.0153380
  • Helle, N., Barkmann, C., Ehrhardt, S., von der Wense, A., Nestoriuc, Y., & Bindt, C. (2016). Postpartum anxiety and adjustment disorders in parents of infants with very low birth weight: Cross-sectional results from a controlled multicentre cohort study. Journal of Affective Disorders, 194, 128–134. https://doi.org/10.1016/j.jad.2016.01.016
  • Meister, R., von Wolff, A., Mohr, H., Nestoriuc, Y., Härter, M., Hölzel, L., & Kriston, L. (2016). Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder. Journal of Clinical Epidemiology, 71, 97–108. https://doi.org/10.1016/j.jclinepi.2015.10.007
  • Colloca, L., & Nestoriuc, Y. (2016). Nocebo and the Patient–Physician Communication. In G. Boniolo & V. Sanchini (Hrsg.), Ethical Counselling and Medical Decision-Making in the Era of Personalised Medicine (S. 29–37). Springer International Publishing. https://doi.org/10.1007/978-3-319-27690-8_4

2015

  • Graef, J. E., Rief, W., French, D. J., Nilges, P., & Nestoriuc, Y. (2015). Fragebogen „Kopfschmerzmanagement und Selbstwirksamkeit “(deutsche Version). Journal Club Schmerzmedizin, 4(04), 201-201.
  • Nestoriuc, Y. (2015). Risiken und Nebenwirkungen ­psychotherapeutischer Behandlung. PiD – Psychotherapie im Dialog, 16(04), 36–39. https://doi.org/10.1055/s-0041-105248
  • Doering, B. K., Nestoriuc, Y., Barsky, A. J., Glaesmer, H., Brähler, E., & Rief, W. (2015). Is somatosensory amplification a risk factor for an increased report of side effects? Reference data from the German general population. Journal of Psychosomatic Research, 79(6), 492–497. https://doi.org/10.1016/j.jpsychores.2015.10.010
  • Schröder, J., Sautier, L., Kriston, L., Berger, T., Meyer, B., Späth, C., Köther, U., Nestoriuc, Y., Klein, J. P., & Moritz, S. (2015). Development of a questionnaire measuring Attitudes towards Psychological Online Interventions–the APOI. Journal of Affective Disorders, 187, 136–141. https://doi.org/10.1016/j.jad.2015.08.044
  • Heisig, S. R., Shedden-Mora, M. C., Hidalgo, P., & Nestoriuc, Y. (2015). Framing and personalizing informed consent to prevent negative expectations: An experimental pilot study. Health Psychology, 34(10), 1033–1037. https://doi.org/10.1037/hea0000217
  • Helle, N., Barkmann, C., Bartz-Seel, J., Diehl, T., Ehrhardt, S., Hendel, A., Nestoriuc, Y., Schulte-Markwort, M., von der Wense, A., & Bindt, C. (2015). Very low birth-weight as a risk factor for postpartum depression four to six weeks postbirth in mothers and fathers: Cross-sectional results from a controlled multicentre cohort study. Journal of Affective Disorders, 180, 154–161. https://doi.org/10.1016/j.jad.2015.04.001
  • Graef, J. E., Rief, W., French, D. J., Nilges, P., & Nestoriuc, Y. (2015). German Language Adaptation of the Headache Management Self-Efficacy Scale (HMSE-G) and Development of a New Short Form (HMSE-G-SF). Headache: The Journal of Head and Face Pain, 55(7), 958–972. https://doi.org/10.1111/head.12564
  • Moritz, S., Fieker, M., Hottenrott, B., Seeralan, T., Cludius, B., Kolbeck, K., Gallinat, J., & Nestoriuc, Y. (2015). No pain, no gain? Adverse effects of psychotherapy in obsessive–compulsive disorder and its relationship to treatment gains. Journal of Obsessive-Compulsive and Related Disorders, 5, 61–66. https://doi.org/10.1016/j.jocrd.2015.02.002
  • Heisig, S. R., Shedden-Mora, M. C., von Blanckenburg, P., Schuricht, F., Rief, W., Albert, U.-S., & Nestoriuc, Y. (2015). Informing women with breast cancer about endocrine therapy: Effects on knowledge and adherence: Informing about endocrine therapy. Psycho-Oncology, 24(2), 130–137. https://doi.org/10.1002/pon.3611
  • von Blanckenburg, P., Schuricht, F., Heisig, S. R., Shedden-Mora, M. C., Rehahn-Sommer, S., Albert, U.-S., Rief, W., & Nestoriuc, Y. (2015). Psychologische Optimierung von Erwartungen zur Prävention von Nocebo-Nebenwirkungen bei Brustkrebs—2 Fallberichte. Verhaltenstherapie, 25(3), 219–227. https://doi.org/10.1159/000377711

2014

  • von Blanckenburg, P., Seifart, U., Conrad, N., Exner, C., Rief, W., & Nestoriuc, Y. (2014). Quality of life in cancer rehabilitation: The role of life goal adjustment: Quality of life: the role of life goal adjustment. Psycho-Oncology, 23(10), 1149–1156. https://doi.org/10.1002/pon.3538
  • Nestoriuc, Y., von Blanckenburg, P., Schuricht, F., Albert, U., & Rief, W. (2014). Nocebo effects in breast cancer treatment: Expectations predict side effects of endocrine therapy. In International Journal of Behavioral Medicine (Vol. 21, pp. S133-S134). 233 Spring St, New York, NY 10013 USA: Springer.
  • Shedden-Mora, M., Nestoriuc, Y., Heisig, S. R., Albert, U. S., Kurth, A., Rief, W., & Hadji, P. (2014). Potentially modifiable determinants of international non-adherence to oral bisphosphonates in women with postmenopausal  osteoporosis. In International Journal of Behavioral Medicine (Vol. 21, pp. S143-S143). 233 Spring St, New York, NY 10013 USA: Springer.
  • Graef, J. E. G., Rief, W., & Nestoriuc, Y. (2014). Evaluation of the German headache management self-efficacy scale. In International Journal of Behavioral Medicine (Vol. 21, pp. S104-S104). 233 Spring St, New York, NY 10013 USA: Springer.
  • Heisig, S., Mora, S., & Nestoriuc, Y. (2014). Coping with medical information is related to nocebo effects in patients with breast cancer: ID 239. Oncology Research and Treatment, 37.
  • Ladwig, I., Rief, W., & Nestoriuc, Y. (2014). What are the Risks and Side Effects of Psychotherapy? – Development of an Inventory for the Assessment of Negative Effects of Psychotherapy (INEP). Verhaltenstherapie, 24(4), 252–263. https://doi.org/10.1159/000367928
  • Ladwig, I., Rief, W., & Nestoriuc, Y. (2014). Welche Risiken und Nebenwirkungen hat Psychotherapie? – Entwicklung des Inventars zur Erfassung Negativer Effekte von Psychotherapie (INEP). Verhaltenstherapie, 24(4), 252–263. https://doi.org/10.1159/000367928
  • Mueller, E. M., Panitz, C., Nestoriuc, Y., Stemmler, G., & Wacker, J. (2014). Panic Disorder and Serotonin Reuptake Inhibitors Predict Coupling of Cortical and Cardiac Activity. Neuropsychopharmacology, 39(2), 507–514. https://doi.org/10.1038/npp.2013.224

2013

  • von Blanckenburg, P., Schuricht, F., Albert, U. S., Rief, W., & Nestoriuc, Y. (2013). Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trial. BMC cancer, 13(1), 426.
  • Graef, J., Rief, W., & Nestoriuc, Y. (2013). Modellprojekt „Biofeedback bei Kopfschmerz“—Chance für Patienten mit Kopfschmerz im Alltag. Suchttherapie, 14(S 01), s-0033-1351501. https://doi.org/10.1055/s-0033-1351501
  • Schuricht, F., Blanckenburg, P. von, Albert, U., Heisig, S., Shedden Mora, M., Rief, W., & Nestoriuc, Y. (2013). Die Relevanz des Nocebo-Effekts während der Antihormontherapie von Brustkrebs. Senologie – Zeitschrift für Mammadiagnostik und -therapie, 10(02), s-0033-1347674. https://doi.org/10.1055/s-0033-1347674
  • Mueller, E. M., Panitz, C., Nestoriuc, Y., Stemmler, G., & Wacker, J. (2013). Brain-heart coupling is elevated in panic disorder.
  • Schuricht, F., & Nestoriuc, Y. (2013). The placebo and nocebo effects in cancer treatment. In Psychological aspects of cancer (pp. 309-326). Springer, Boston, MA.

2012

  • Glombiewski, J. A., Nestoriuc, Y., Rief, W., Glaesmer, H., & Braehler, E. (2012). Medication Adherence in the General Population. PLoS ONE, 7(12), e50537. https://doi.org/10.1371/journal.pone.0050537
  • von Blanckenburg, P., Schuricht, F., Albert, U. S., Rief, W., & Nestoriuc, Y. (2012). Side effect prevention training – A program to enhance beast cancer patients‘ quality of life during adjuvant endocrine therapy. In International Journal of Behavioral Medicine (Vol. 19, pp. S170-S170). 233 Spring St, New York, NY 10013 USA: Springer.
  • Auer, C. J., Laferton, J., Nestoriuc, Y., Doering, B. K., & Rief, W. (2012). The relationship between pre-operative expectations and post-operative health outcomes. A meta-analytical review. In International Journal of Behavioral Medicine (Vol. 19, pp. S172-S173). 233 Spring St, New York, NY 10013 USA: Springer.
  • Schuricht, F., Von Blanckenburg, P., Albert, U. S., Rief, W., & Nestoriuc, Y. (2012). Expected symptom coping and quality of live in breast cancer patients receiving endocrine therapy. In International Journal of Behavioral Medicine (Vol. 19, pp. S170-S170). 233 Spring St, New York, NY 10013 USA: Springer.
  • Mueller, E. M., Panitz, C., Nestoriuc, Y., Stemmler, G., & Wacker, J. (2012). Brain-heart coupling is elevated in panic disorder – Evidence from covariation of evoked single-trial EEG and cardiac response. In Psychophysiology (Vol. 49, pp. S111-S111). 111 River St, Hoboken 07030-5774, NJ USA: Wiley-Blackwell.
  • Nestoriuc, Y., Berking, M., & Rief, W. (2012). Psychotherapieforschung. In M. Berking & W. Rief (Hrsg.), Klinische Psychologie und Psychotherapie für Bachelor (Bd. 5024, S. 165–179). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-25523-6_15
  • Nestoriuc, Y., & Rief, W. (2012). Risiken und Nebenwirkungen von Verhaltenstherapie. Risiken und Nebenwirkungen von Psychotherapie: Erfassung, Bewältigung, Risikovermeidung (S. 59–74). Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft. Chicago

2011

  • Mora, M. S., Nestoriuc, Y., & Rief, W. (2011). Lessons learned from placebo groups in antidepressant trials. Philosophical Transactions of the Royal Society B: Biological Sciences, 366(1572), 1879-1888. https://doi.org/10.1098/rstb.2010.0394
  • Rief, W., Barsky, A. J., Glombiewski, J. A., Nestoriuc, Y., Glaesmer, H., & Braehler, E. (2011). Assessing general side effects in clinical trials: Reference data from the general population: GASE IN CLINICAL TRIALS. Pharmacoepidemiology and Drug Safety, 20(4), 405–415. https://doi.org/10.1002/pds.2067
  • Kühl, K., Klinge, J., Nestoriuc, Y., Winterkamp, S., Sczepanski, B., Bönsch, M., Rief, W., & Kenn, K. (2011). Experimentelle Untersuchung zum Einfluss von akutem Stresserleben bei COPD. Pneumologie, 65(S 01), s-0031-1272229. https://doi.org/10.1055/s-0031-1272229

2010

  • Barsky, A. J., Ahern, D. K., Orav, E. J., Nestoriuc, Y., Liang, M. H., Berman, I. T., Kingsbury, J. R., Sy, J. T., & Wilk, K. G. (2010). A Randomized Trial of Three Psychosocial Treatments for the Symptoms of Rheumatoid Arthritis. Seminars in Arthritis and Rheumatism, 40(3), 222–232. https://doi.org/10.1016/j.semarthrit.2010.04.001